← Back to Search

Immunotherapy

Treatment for Peanut Allergy

Phase 1 & 2
Waitlist Available
Led By Simon A Ronald, MD
Research Sponsored by Scripps Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights

Study Summary

This trial found that three intralymphatic injections of peanut allergen given one month apart induced tolerance to peanut in peanut allergic people.

Eligible Conditions
  • Peanut Allergy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Peanut tolerance

Trial Design

1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment1 Intervention
Peanut ILIT

Find a Location

Who is running the clinical trial?

Scripps HealthLead Sponsor
54 Previous Clinical Trials
11,666 Total Patients Enrolled
The Scripps Research InstituteOTHER
30 Previous Clinical Trials
10,582 Total Patients Enrolled
Simon A Ronald, MDPrincipal InvestigatorScripps Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Novel Treatment for Patients With Peanut Allergy: Intralymphatic Immunotherapy
Ronald A Simon 2021. "Novel Treatment for Patients With Peanut Allergy: Intralymphatic Immunotherapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04200989.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top